{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:23:55Z","timestamp":1790270635100,"version":"4.1.0"},"reference-count":59,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Progressive waves of coronavirus disease 2019 (COVID-19) have been driven by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants carrying mutations in the spike glycoprotein, particularly in immunodominant regions such as the receptor-binding domain (RBD) and the N-terminal domain (NTD). These mutations can alter antigenic surfaces and are associated with changes in antibody recognition and vaccine-induced protection. Integrating experimental neutralisation data with computational analyses may contextualise variant-associated differences in antibody responses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Neutralisation responses were evaluated using a pseudovirus-based luciferase reporter assay including SARS-CoV-2 spike proteins from B.1 (Wuhan), B.1.617.2, AY.2 (Delta), and B.1.1.529 (Omicron). Plasma samples from three cohorts: naturally infected (I), vaccinated (V), and vaccinated-infected individuals (V+I), along with RBD-directed monoclonal antibody CR3022, were assessed to determine neutralizing titres (NT50). In parallel, spike sequences were analysed using epitope prediction, antigenicity profiling, and structural modelling. Docking simulations of CR3022 with variant RBDs were performed using HADDOCK, and binding parameters were estimated using PRODIGY.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Neutralisation responses varied across cohorts and viral variants, reflecting differences in immune exposure history. Plasma from V group individuals showed comparatively higher neutralisation titre, whereas B.1.617.2 and B.1.1.529 exhibited reduced susceptibility to neutralisation by infection-elicited antibodies. Computational analyses indicated variant-associated differences in predicted antigenicity and epitope landscapes within the RBD and NTD. Structural modelling and docking suggested that spike mutations may influence the CR3022-RBD interaction interface, with corresponding changes in predicted binding affinity across variants. These computational observations provide structural context for experimentally observed trends in reduced neutralisation but do not establish a direct mechanistic relationship.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study provides a combined experimental and computational characterization of SARS-CoV-2 variant-specific neutralisation across infection, vaccination and hybrid immunity-driven cohorts. The integration of pseudovirus neutralisation data with structural and in silico analyses offers a hypothesis-generating framework to contextualize observed differences in antibody responses and epitope recognition across variants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1810369","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:36:52Z","timestamp":1783316212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Structural and functional dissection of neutralisation differences among SARS-CoV-2 variants using antigenicity prediction and CR3022 binding analysis"],"prefix":"10.3389","volume":"17","author":[{"given":"Jyoti","family":"Sawant","sequence":"first","affiliation":[{"name":"ICMR-National Institute of Translational Virology and AIDS Research","place":["Pune, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Patil","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Translational Virology and AIDS Research","place":["Pune, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Thakar","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Translational Virology and AIDS Research","place":["Pune, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swarali","family":"Kurle","sequence":"additional","affiliation":[{"name":"ICMR-National Institute of Translational Virology and AIDS Research","place":["Pune, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108890","article-title":"The effect of spike mutations on SARS-CoV-2 neutralization","volume":"34","author":"Rees-Spear","year":"2021","journal-title":"Cell Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"4350","DOI":"10.1038\/s41467-022-31929-6","article-title":"Differential neutralization and inhibition of SARS-CoV-2 variants by antibodies elicited by COVID-19 mRNA vaccines","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.immuni.2021.06.003","article-title":"Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species","volume":"54","author":"Wang","year":"2021","journal-title":"Immunity"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-023-00878-2","article-title":"The evolution of SARS-cov-2","volume":"21","author":"Markov","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq8276","article-title":"Design of the SARS-CoV-2 RBD vaccine antigen improves neutralizing antibody response","volume":"8","author":"Dickey","year":"2022","journal-title":"Sci Adv"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines11040771","article-title":"Potent NTD-targeting neutralizing antibodies against SARS-CoV-2 selected from a synthetic immune system","volume":"11","author":"Li","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1093\/ve\/veab069","article-title":"The ongoing evolution of variants of concern and interest of SARS-CoV-2 in Brazil revealed by convergent indels in the amino (N)-terminal domain of the spike protein","volume":"7","author":"Resende","year":"2021","journal-title":"Virus Evol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.chom.2021.02.003","article-title":"Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies","volume":"29","author":"Greaney","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.130","article-title":"Antigenicity comparison of SARS-CoV-2 Omicron sublineages with other variants contained multiple mutations in RBD","volume":"3","author":"Li","year":"2022","journal-title":"MedComm (2020)"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.00922-23","article-title":"Mutations in S2 subunit of SARS-CoV-2 Omicron spike strongly influence its conformation, fusogenicity, and neutralization sensitivity","volume":"97","author":"Kumar","year":"2023","journal-title":"J Virol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cell.2021.01.037","article-title":"Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity","volume":"184","author":"Thomson","year":"2021","journal-title":"Cell"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02975-21","article-title":"Cross-neutralization of emerging SARS-CoV-2 variants of concern by antibodies targeting distinct epitopes on spike","volume":"12","author":"Changrob","year":"2021","journal-title":"mBio"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02473-21","article-title":"A combination of receptor-binding domain and N-terminal domain neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants","volume":"12","author":"Haslwanter","year":""},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-022-00809-7","article-title":"SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies","volume":"21","author":"Cox","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101668","article-title":"Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination","volume":"5","author":"Voss","year":""},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1126\/science.abb7269","article-title":"A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV","volume":"368","author":"Yuan","year":"2020","journal-title":"Sci (New York NY)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","article-title":"BepiPred-2.0: improving sequence-based B-cell epitope prediction using conformational epitopes","volume":"45","author":"Jespersen","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(90)80535-q","article-title":"A semi-empirical method for prediction of antigenic determinants on protein antigens","volume":"276","author":"Kolaskar","year":"1990","journal-title":"FEBS Lett"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/prot.21078","article-title":"Prediction of continuous B-cell epitopes in an antigen using recurrent neural network","volume":"65","author":"Saha","year":"2006","journal-title":"Proteins"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-9-514","article-title":"ElliPro: a new structure-based tool for the prediction of antibody epitopes","volume":"9","author":"Ponomarenko","year":"2008","journal-title":"BMC Bioinf"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-4","article-title":"VaxiJen: a server for prediction of protective antigens, tumour antigens and subunit vaccines","volume":"8","author":"Doytchinova","year":"2007","journal-title":"BMC Bioinf"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btaa058","article-title":"QMEANDisCo-distance constraints applied on model quality estimation","volume":"36","author":"Studer","year":"2020","journal-title":"Bioinformatics"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.729513","article-title":"Structural biology in the clouds: The WeNMR-EOSC ecosystem","volume":"8","author":"Honorato","year":"2021","journal-title":"Front Mol Biosci"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41596-024-01011-0","article-title":"The HADDOCK2.4 web server for integrative modeling of biomolecular complexes","volume":"19","author":"Honorato","year":"2024","journal-title":"Nat Protoc"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/prot.26018","article-title":"PDB-tools web: A user-friendly interface for the manipulation of PDB files","volume":"89","author":"Jim\u00e9nez-Garc\u00eda","year":"2021","journal-title":"Proteins"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.7490\/f1000research.1117109.1","article-title":"pdb-tools: a swiss army knife for molecular structures","volume":"7","author":"Rodrigues","year":"2018","journal-title":"F1000Research"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-92745\/v1","article-title":"Affinity maturation of cross-reactive CR3022 antibody against the receptor binding domain of SARS-CoV-2 via in silico site-directed mutagenesis","author":"Pradhan","year":""},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.7554\/elife.07454","article-title":"Contacts-based prediction of binding affinity in protein\u2013protein complexes","volume":"4","author":"Vangone","year":"2015","journal-title":"eLife"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btw514","article-title":"PRODIGY: a web server for predicting the binding affinity of protein\u2013protein complexes","volume":"32","author":"Xue","year":"2016","journal-title":"Bioinformatics"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera: a visualization system for exploratory research and analysis","volume":"25","author":"Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2852-1","article-title":"SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies","volume":"588","author":"Barnes","year":"2020","journal-title":"Nature"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2021.04.010","article-title":"An NTD supersite of attack","volume":"29","author":"Lok","year":"2021","journal-title":"Cell Host Microbe"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2174\/18755402mtewuotew2","article-title":"Mechanistic insights to the binding of antibody CR3022 against RBD from SARS-CoV and HCoV-19\/SARS-CoV-2: A computational study","volume":"24","author":"Yu","year":"2021","journal-title":"Comb Chem High Throughput Screening"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100764","article-title":"Enhanced antibody responses in fully vaccinated individuals against pan-SARS-CoV-2 variants following Omicron breakthrough infection","volume":"3","author":"Jeong","year":"2022","journal-title":"Cell Rep Med"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn7842","article-title":"Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses","volume":"14","author":"Sievers","year":"2022","journal-title":"Sci Transl Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.25.428137","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04387-1","article-title":"Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization","volume":"602","author":"Cele","year":""},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04389-z","article-title":"Considerable escape of SARS-CoV-2 Omicron to antibody neutralization","volume":"602","author":"Planas","year":"2022","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/j.cell.2021.03.013","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","volume":"184","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04386-2","article-title":"Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift","volume":"602","author":"Cameroni","year":"2022","journal-title":"Nature"},{"key":"B44","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/nejmc2119641","article-title":"Plasma neutralization of the SARS-CoV-2 Omicron variant","volume":"386","author":"Schmidt","year":"2022","journal-title":"N Engl J Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2022.104076","article-title":"Omicron's binding to sotrovimab, casirivimab, imdevimab, CR3022, and sera from previously infected or vaccinated individuals","volume":"25","author":"Mader","year":"2022","journal-title":"iScience"},{"key":"B46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2139\/ssrn.3613273","article-title":"Neutralization of SARS-CoV-2 by destruction of the prefusion spike","volume":"28","author":"Huo","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110428","article-title":"Cryo-EM structure of the SARS-CoV-2 Omicron spike","volume":"38","author":"Cerutti","year":"2022","journal-title":"Cell Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-022-04581-9","article-title":"Molecular basis of receptor binding and antibody neutralization of Omicron","volume":"604","author":"Hong","year":"2022","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.1038\/s41467-022-32665-7","article-title":"Omicron SARS-CoV-2 mutations stabilize spike up-RBD conformation and lead to a non-RBM-binding monoclonal antibody escape","volume":"13","author":"Zhao","year":"2022","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.medidd.2021.100114","article-title":"The delta variant mutations in the receptor binding domain of SARS-CoV-2 show enhanced electrostatic interactions with the ACE2","volume":"13","author":"Goher","year":"2021","journal-title":"Med Drug Discov"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.3390\/biom12121742","article-title":"SARS-CoV-2 delta variant: Interplay between individual mutations and their allosteric synergy","volume":"12","author":"Chan","year":"2022"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2021.08.036","article-title":"Mutation-induced changes in the receptor-binding interface of the SARS-CoV-2 delta variant B.1.617.2 and implications for immune evasion","volume":"574","author":"Baral","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02732-21","article-title":"Update on SARS-CoV-2 omicron variant of concern and its peculiar mutational profile","volume":"10","author":"Alkhatib","year":"2022","journal-title":"Microbiol Spectr"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-04385-3","article-title":"Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies","volume":"602","author":"Cao","year":"2022","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"10130","DOI":"10.1038\/s41467-025-65099-y","article-title":"Spike conformational and glycan heterogeneity associated with furin cleavage causes incomplete neutralization of SARS-CoV-2","volume":"16","author":"Kumar","year":"2025","journal-title":"Nat Commun"},{"key":"B56","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3390\/v14020186","article-title":"Structure based affinity maturation and characterizing of SARS-CoV antibody CR3022 against SARS-CoV-2 by computational and experimental approaches","volume":"14","author":"Yu","year":"2022"},{"key":"B57","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1016\/j.cell.2020.06.025","article-title":"Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies","volume":"182","author":"Barnes","year":"2020","journal-title":"Cell"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/nature01188","article-title":"HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites","volume":"420","author":"Kwong","year":"2002","journal-title":"Nature"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1101\/2020.06.11.146522","article-title":"Beyond shielding: The roles of glycans in SARS-CoV-2 spike protein","author":"Casalino","year":"2020","journal-title":"bioRxiv"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810369\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T05:36:53Z","timestamp":1783316213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1810369\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":59,"alternative-id":["10.3389\/fimmu.2026.1810369"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1810369","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"article-number":"1810369"}}